Teladoc Health Inc's Q3 results were mixed, with revenue of $660.24 million missing estimates of $664.11 million, but a 35 cent loss per share beating estimates for a 37 cent loss. Access fees revenue increased 8% YoY, while other revenue grew 10%. U.S. revenue was up 7% and International revenue jumped 17%. However, total visits decreased 4% to 4.4 million. The company expects Q4 revenue to be between $658 million and $683 million, below estimates of $686.56 million. Teladoc shares were down 6.18% at $17.01.